Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	82	54	63	112	200	533
Market Cap Growth	67.03%	-15.02%	-43.14%	-44.18%	-62.51%	-7.48%
Enterprise Value	-29	-74	-25	-29	-6	271
PE Ratio	-	-0.88	-0.68	-0.86	-3.21	-5.46
PS Ratio	-	-	-	17.83	2.53	33.39
PB Ratio	2.52	1.31	0.77	0.66	0.83	1.95
P/FCF Ratio	2.99	2.39	-0.75	-1.17	-3.15	-6.22
P/OCF Ratio	2.96	2.37	-0.75	-1.19	-3.17	-6.34
EV/Sales Ratio	-	-	-	-4.58	-0.08	16.99
EV/EBITDA Ratio	0.75	1.22	0.27	0.22	0.11	-2.77
EV/EBIT Ratio	0.74	1.21	0.27	0.22	0.10	-2.76
EV/FCF Ratio	-1.38	-3.29	0.29	0.30	0.10	-3.17
Debt / Equity Ratio	0.06	0.06	0.04	0.04	0.04	0.04
Debt / EBITDA Ratio	-0.04	-0.04	-0.04	-0.05	-0.16	-0.13
Debt / FCF Ratio	0.07	0.10	-0.04	-0.07	-0.16	-0.14
Quick Ratio	2.92	3.32	5.68	9.14	8.91	11.35
Current Ratio	3.02	3.41	5.95	9.59	9.19	11.57
Asset Turnover	0	0	0	0.03	0.26	0.06
Return on Equity (ROE)	-120.60%	-117.70%	-81.70%	-59.50%	-24.10%	-49.10%
Return on Assets (ROA)	-54.80%	-72.40%	-70.30%	-52.90%	-20.80%	-36.70%
Return on Capital (ROIC)	-199.10%	-165.31%	-109.27%	-75.65%	-25.84%	-35.98%
Earnings Yield	-62.39%	-113.62%	-146.80%	-116.44%	-31.11%	-18.32%
FCF Yield	33.48%	41.78%	-133.35%	-85.76%	-31.75%	-16.07%
Buyback Yield / Dilution	-28.99%	-13.47%	-11.85%	-22.17%	-34.92%	-15.16%
Total Shareholder Return	-28.99%	-13.47%	-11.85%	-22.17%	-34.92%	-15.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).